Global DNA Repair Drugs Market
Global DNA Repair Drugs Market Poised for Remarkable Growth: Key Insights and Projections for 2024-2034
January 30, 2024 03:33 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global DNA Repair Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. Emerging Trends and...
Global DNA Repair Drugs Market
DNA Repair Drugs Market Projected for Accelerated Growth, New Research Highlights Industry Trends and Opportunities
January 25, 2024 20:23 ET | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "DNA Repair Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.As the fight against cancer continues, the...
Global Market for microRNA (miRNA)
microRNA (miRNA) Global Market is Projected to Reach $840.8 Billion by 2030: Increasing Demand for Liquid Biopsies to Drive Growth
June 30, 2023 05:03 ET | Research and Markets
Dublin, June 30, 2023 (GLOBE NEWSWIRE) -- The "microRNA (miRNA): Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for microRNA (miRNA)...
Full Latin without Latin logo.png
CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals
February 01, 2023 19:14 ET | Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Results released today from a clinical study have shown that the drug afamelanotide can reduce critical skin damage caused by ultraviolet (UV)...
Full Latin without Latin logo.png
CLINUVEL Trial Results Show Drug Reduces DNA Damage
January 15, 2023 18:23 ET | Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a genetic DNA repair disorder show that a new drug – afamelanotide – may be able to reduce the development of...
Global DNA Repair Drugs Market
Worldwide DNA Repair Drugs Industry to 2026 - by Technology Type, Application and Region
February 25, 2022 09:23 ET | Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "DNA Repair Drugs: Global Markets" report has been added to ResearchAndMarkets.com's offering. This report provides an in-depth examination of the...
22157.jpg
Global microRNA (miRNA) Market Research Report 2021: Increasing Incidence of Infectious Diseases and Chronic Conditions to Help miRNA Market Gallop Ahead
January 19, 2022 06:28 ET | Research and Markets
Dublin, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The "microRNA (miRNA) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global microRNA (miRNA) Market...
22157.jpg
Global Targeted Therapeutics Market Research Report 2021: Market will Surpass $100+ Billion in 2021 - Forecast to 2026
December 15, 2021 09:03 ET | Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Targeted Therapeutics Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for targeted...
22157.jpg
Global DNA Damage Response Targeting Therapeutics Market Report 2021: Current Landscape and the Likely Adoption of DNA Damage Response Targeting Therapeutics in Healthcare Over the Next Decade
October 06, 2021 06:23 ET | Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "DNA Damage Response Targeting Therapeutics Market by Target Disease Indication, Therapeutic Area, Target Molecule, Type of Molecule, Route of...
Full Latin without Latin logo.png
CLINUVEL expands DNA Repair Program
March 23, 2021 20:10 ET | Clinuvel Pharmaceuticals Limited
SCENESSE® (afamelanotide 16mg) to be evaluated in xeroderma pigmentosum variant (XP-V) MELBOURNE, Australia, March 24, 2021 (GLOBE NEWSWIRE) -- CLINUVEL has expanded its clinical program to...